Skip to main content
Eagle Pharmaceuticals, Inc. (EGRX)
NASDAQ: EGRX · IEX Real-Time Price · USD
5.72
-0.02 (-0.35%)
At close: Jul 26, 2024, 4:00 PM
5.75
+0.03 (0.52%)
After-hours: Jul 26, 2024, 5:37 PM EDT

Eagle Pharmaceuticals Revenue

Eagle Pharmaceuticals had revenue of $64.65M in the quarter ending June 30, 2023, a decrease of -12.80%. This brings the company's revenue in the last twelve months to $257.55M, down -5.38% year-over-year. In the year 2022, Eagle Pharmaceuticals had annual revenue of $316.61M with 84.56% growth.

Revenue (ttm)
$257.55M
Revenue Growth
-5.38%
P/S Ratio
0.29
Revenue / Employee
$1,922,022
Employees
134
Market Cap
74.29M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2022316.61M145.06M84.56%
Dec 31, 2021171.55M-16.26M-8.66%
Dec 31, 2020187.80M-8.09M-4.13%
Dec 31, 2019195.89M-17.42M-8.17%
Dec 31, 2018213.31M-23.40M-9.88%
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sep 30, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Spero Therapeutics 110.98M
MDxHealth 75.33M
SHL Telemedicine 57.08M
Gritstone bio 15.65M
Ovid Therapeutics 473.54K
Genelux 8.00K
Revenue Rankings

EGRX News

More News